Curriculum Vitaes
Profile Information
- Affiliation
- Professor, Research Promotion Headquarters, Center for Society-Academia Collaboration , Fujita Health UniversityProfessor, Premium Research Institute for Human Metaverse Medicine, Osaka University
- Degree
- MD(Mar, 1984)Ph.D.(Mar, 1988)
- Researcher number
- 60204533
- J-GLOBAL ID
- 200901003262194571
- researchmap Member ID
- 1000305140
- External link
Research Interests
6Research Areas
4Research History
10-
Oct, 2007 - Mar, 2024
-
Apr, 2004 - Sep, 2007
-
Apr, 2001 - Mar, 2004
Education
2-
Mar, 1984 - Apr, 1988
-
Apr, 1978 - Mar, 1984
Awards
12-
Jan, 2020
-
2014
-
2013
-
2013
Papers
472-
Nuclear Medicine and Biology, 156-157 109623-109623, May, 2026
-
Journal of proteome research, 25(4) 1878-1891, Apr 3, 2026Proteases play crucial roles in numerous biological processes through specific protein cleavage, and their dysregulation has been implicated in various diseases. To better understand protease specificity, we developed a lauroylation-assisted proteomic identification of protease cleavage sites (PICS) workflow that labels and enriches targeted protease-generated neo-N-termini using economical reagents and standard laboratory equipment. The lauroylation enables both discrimination of the neo-N-termini in LC-MS/MS and efficient enrichment on a C18 StageTip by exploiting its hydrophobicity. Among tested acylations, we found lauroylation to be optimal for PICS and improved enrichment and fractionation conditions. We demonstrated that this method can profile specificities of multiple proteases with high sensitivity. Furthermore, we extended this concept to N-terminomics to examine proteolysis at the protein level. Protein N-terminal dimethylation is used for labeling, and tryptic internal peptides are lauroylated for removal. This approach identified over 1500 cleavages induced by etoposide, including 912 Asp-cleaved sites consistent with caspase-3 motifs and sensitive to inhibition by Z-DEVD-FMK. Additionally, 2286 protein N-termini were identified in untreated cells, including 1794 non-ORF N-termini with 665 previously annotated processing sites. These results demonstrate that our workflow provides a simple, economical, and widely applicable method for characterizing protease cleavage at both peptide and protein levels.
-
International Immunopharmacology, 172 116138-116138, Mar, 2026
-
Cancer & Metabolism, 13(1), Dec 2, 2025
-
Scientific Reports, 15(1), Sep 26, 2025 Peer-reviewed
Misc.
440-
日本癌学会学術総会抄録集(Web), 83rd, 2024
-
日本癌学会学術総会抄録集(Web), 82nd, 2023
-
日本癌学会学術総会抄録集(Web), 82nd, 2023
-
Pharma Medica, 39 79-8, May, 2021 InvitedLead authorCorresponding author
-
JOURNAL OF NUCLEAR MEDICINE, 61, May 1, 2020
-
日本癌学会学術総会抄録集(Web), 78th, 2019
-
Proceedings for Annual Meeting of The Japanese Pharmacological Society, 92 3-P-109, 2019<p>Targeted alpha therapy is receiving much attention in the field of theranostics because of its high cytotoxic effect to the targeting cancer cells. However, physiological uptakes in non-targeted organs are also observed in the targeted alpha therapy, which might lead to the severe side effects. We should consider about both maximizing the treatment effect in the tumor and minimizing the side effects in the organs at risk. From this viewpoint, decision of targeting molecule was most important.</p><p>We selected LAT1 as molecular target. LAT1 is one of the amino acid transporters. LAT1 has highly specificity to cancer tissues. </p><p>We developed next-generation internal radiotherapy using chemicals targeting LAT1. First, we synthesized alpha-methyl-L-tylosine labeled with 211At. 211At was produced by the cyclotron, and then quickly purified and combined to alpha-methyl-L-tyrosine (211At-AAMT). Next, we performed cytotoxicity evaluation of 211At-AAMT using PANC-1 cells, Human pancreas cancer cell lines. We also detected the DNA damage by 211At-AAMT. As a result, cell death and specificity were confirmed in 211At-AAMT. We also found the anti-cancer effects in vivo study. In the immediate future, we will examine that the effects of 211At-AAMT using several kinds of tumor-bearing models.</p>
-
日本癌学会総会記事, 77回 1280-1280, Sep, 2018
-
Atlas of Science (http://atlasofscience.org/), Jan, 2018
-
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 40(11) 1692-1700, 2017
Books and Other Publications
41Presentations
38Professional Memberships
16Research Projects
53-
科学研究費助成事業, 日本学術振興会, Apr, 2022 - Mar, 2025
-
科学研究費助成事業, 日本学術振興会, Apr, 2022 - Mar, 2025
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2019 - Mar, 2022
-
Study on the effects of amino acid availability on life span and the underlying molecular mechanismsGrants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Jun, 2018 - Mar, 2020
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2015 - Mar, 2018